Pancreatic Cancer Research

ResearcherOregon Health & Science UniversityActive in the last 2 years

Kevin Hawthorne

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2657-8762, 0000-0002-9195-5720; OpenAlex author ID A5008953662, A5019518419, A5060649081. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
46
Papers, trials and grants by year

2025: 5 papers · 2026: 4 papers

Papers 9

  1. The Posttranscriptional Regulator HuR Promotes Immune Evasion in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1136/jitc-2025-sitc2025.1250↗
  2. Sympathetic nerve-fibroblast crosstalk drives nerve injury, fibroblast activation, and matrix remodeling in pancreatic cancer. Co-author DOI 10.1172/jci.insight.192814↗
  3. Spatially Resolved Epithelial States Delineate Immunosuppressive Niches of Impaired Myeloid Antigen Presentation in PDAC Co-author DOI 10.64898/2026.07.28.741300↗
  4. Epigenetic progression of pancreatic cancer to aggressive subtypes involves alternate routes of lineage reprogramming in subtype-intermediate progenitor cells Co-author DOI 10.64898/2026.09.28.754674↗
  5. Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer. Co-author DOI 10.1038/s43018-024-00881-3↗
  6. Post-transcriptional regulator HuR promotes immune evasion in pancreatic ductal adenocarcinoma Co-author DOI 10.1101/2025.02.07.632847↗
  7. Myc and Kras cooperate in adult acinar cells to drive phenotypic heterogeneity, metastasis, and therapeutic resistance in a novel pancreatic cancer mouse model Co-author DOI 10.1101/2025.07.14.664767↗
  8. The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-24-3437↗
  9. HuR-Regulated Extracellular Vesicles Promote Endothelial Cell Remodeling in Pancreatic Cancer. Co-author DOI 10.1158/2767-9764.crc-25-0355↗

Closest collaborators

The 25 strongest of 46 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rosalie C. Sears · 9 shared papers, 2025–2026 · strength 1.93
  2. Jonathan Robert Brody · 5 shared papers, 2025–2026 · strength 0.98
  3. Lisa M. Coussens · 4 shared papers, 2025–2026 · strength 0.76
  4. Motoyuki Tsuda · 4 shared papers, 2025–2026 · strength 0.74
  5. Ellen M. Langer · 4 shared papers, 2025–2026 · strength 0.74
  6. Jennifer M. Finan · 3 shared papers, 2025–2026 · strength 0.64
  7. Yifei Guo · 3 shared papers, 2025–2026 · strength 0.64
  8. Zheng Xia · 3 shared papers, 2025–2026 · strength 0.64
  9. Canping Chen · 3 shared papers, 2025–2026 · strength 0.64
  10. Katie E. Blise · 3 shared papers, 2025–2026 · strength 0.60
  11. Patrick Joseph Worth · 3 shared papers, 2025–2026 · strength 0.58
  12. Brett C. Sheppard · 3 shared papers, 2025–2026 · strength 0.57
  13. Jason M. Link · 3 shared papers, 2025–2026 · strength 0.57
  14. Katherine R. Pelz · 3 shared papers, 2025–2026 · strength 0.55
  15. Isabel A. English · 3 shared papers, 2025 · strength 0.49
  16. Aaron J. Grossberg · 2 shared papers, 2025–2026 · strength 0.43
  17. Grace A. McCarthy · 2 shared papers, 2025–2026 · strength 0.43
  18. Robert L Eil · 2 shared papers, 2025–2026 · strength 0.43
  19. Mara H. Sherman · 2 shared papers, 2025–2026 · strength 0.42
  20. Vidhi M. Shah · 2 shared papers, 2025–2026 · strength 0.38
  21. Amy S. Farrell · 2 shared papers, 2025 · strength 0.33
  22. Brittany L. Allen-Petersen · 2 shared papers, 2025 · strength 0.33
  23. Terry K. Morgan · 2 shared papers, 2025 · strength 0.33
  24. Michael Angelo · 1 shared paper, 2026 · strength 0.28
  25. Cameron R. Walker · 1 shared paper, 2026 · strength 0.28

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.